Australian VC firm, Brandon Capital Partners, has just raised another $210 million to invest in commercialising medical research, and is already on the hunt for another $250 million as it edges towards $1 billion in science investments. The 5th Medical Research Commercialisation Fund, MRCF5, raised AU$210 million from existing investors, taking the total in the… Read more »
Three $200 million Aussie funds have launched so far this year. Is this a welcome change in the weather for startups?
The announcement that Blackbird Ventures had raised $200 million for its second fund was big news on September 15. Two days ago, SEEK cofounder Paul Bassat joined the $200 million club with his new venture capital fund. The fund is backed by major investors including James Packer, some super funds, and a plethora of other wealthy individuals also focused on investing in Australia’s startup ecosystem.
Brandon Capital launches $200M venture fund for life science startups, backed by Australian super funds
With support from AustralianSuper, StatewideSuper, HESTA and Hostplus Industry Super Funds, Brandon Capital has raised a total of AU$200 million, making the firm’s third Medical Research Commercialisation Fund (MRCF3) the largest ever life science venture fund in Australia.